Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Oct 20, 2019
Johnson & Johnson’s Talc Problems Hit Another Bump
Image Shown: Johnson & Johnson’s embattled ‘Baby Care’ segment performed poorly during the third quarter of 2019. Image Source: Johnson & Johnson – IR Presentation. Johnson & Johnson was back in the news Friday October 18 when the company announced it was voluntarily recalling “a single lot” of its embattled Johnson’s Baby Powder product in the US due to alleged asbestos contamination risks. The US Food and Drug Administration tested a single bottle from this lot, according to Johnson & Johnson, with the federal regulator noting that sub-trace levels (no greater than 0.00002%) of chrysotile asbestos had been detected in the bottle. Johnson & Johnson plans to vigorously contest these allegations and maintains that its talc products don’t contain asbestos. Oct 18, 2019
Philip Morris International: Free Cash Flow King With Upside Potential
Image Shown: Philip Morris International's Marlboro cigarette brand remains very popular worldwide. Pricing power is essential to offsetting declines in traditional cigarette sales volumes as the company positions itself for alternative tobacco products to become a larger part of its revenue streams. Image Source: Philip Morris International – Third quarter 2019 earnings presentation. We continue to like Philip Morris International as a quality high-yield play with good dividend coverage in a low interest rate environment. Strong pricing power enables the firm to offset sales declines of its traditional cigarette volumes as the company waits for its alternative smoking offerings (like IQOS) to represent a bigger chunk of company-wide sales. Please note that foreign currency headwinds remain significant, but manageable. As of this writing, Philip Morris International yields 5.8%. Oct 16, 2019
BREAKING: UAW-GM Reaches Deal, More Coming from Valuentum Soon...
BREAKING: UAW-GM Reaches Deal, More Coming from Valuentum Soon... Oct 15, 2019
Johnson & Johnson Raises Full-Year Guidance Yet Again
Mounting legal liabilities have been weighing negatively against Johnson & Johnson and its stock price over the past year as investors fret about the size of these potential settlements/judgements. We see the firm’s latest quarterly performance and guidance increase for 2019 as validation of the strength of Johnson & Johnson’s broad-based healthcare business model. Once the market gets a better idea of Johnson & Johnson’s total potential legal liabilities, shares could begin to converge towards their intrinsic value given the underlying strength in the firm’s businesses. Our fair value estimate for shares of JNJ stands at ~$150 per share. Aug 28, 2019
Smucker Cuts Guidance with Weakness Widespread
Image Source: J.M. Smucker Company -- IR Presentation. Smucker’s revenue and earnings both missed estimates for the quarter ended July 31, while management lowered the company’s full year guidance for fiscal 2020. We've taken a close look at our valuation model, but we haven't made any material changes to the fair value estimate. Aug 20, 2019
Owens-Illinois’ Debt Load Is Daunting, We Are Staying Away From This Value Trap
Image Source: Owens-Illinois Inc -- IR Presentation. Due to Owens-Illinois’ onerous leverage, guidance cut, and signs that the global economy is slowing down, we are staying far from the name. While shares of OI trade decently below the low end of our fair value estimate range we caution that the market is likely right on this one. Owens-Illinois is another example of a Value Trap. Aug 6, 2019
Realty Income Posts Solid Earnings, Acquires Overseas Real Estate for First Time
Image Source: Realty Income Corporation – IR Presentation. We liked what we saw in Realty Income’s second quarter 2019 earnings report, and we appreciate management reiterating guidance for the full year. While Realty Income’s payout ratio could be a tad lower, its consistent financial performance and solid investment grade credit ratings indicate its dividend is secure for the time being. Jul 18, 2019
Kinder Morgan Modestly Disappoints But Its Problems Are Transitory
Image Shown: Kinder Morgan Inc expects a lot of organic growth opportunities will be generated via surging domestic demand for natural gas and rising natural gas export capacity in the US. Image Source: Kinder Morgan Inc – IR Presentation. We remain optimistic on Kinder Morgan’s dividend growth opportunities, and our fair value estimate still stands at $23 per share. Jul 13, 2019
Reviewing PepsiCo’s Latest Earnings
Image Source: Mike Mozart. Shares of PEP trade well above our fair value estimate and as of this writing are trading near the top end of our fair value range. We aren’t looking to add PEP to any newsletter portfolio, but we appreciate PepsiCo’s improving operational and financial performance in the face of foreign currency headwinds, trade wars, and other exogenous events outside of its control. Jul 12, 2019
3M Dividend Still Strong for Now in the Face of Legal Troubles
Image Source: 3M Company – IR Presentation. While 3M has good dividend coverage, it could be better. In the event PFAS-related lawsuits end up going against 3M, the company may have to consider suspending its share buyback program in order to maintain its current payout while covering legal settlements. The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
